← FDA Drug Approvals (Drugs@FDA)

YORVIPATH

NDA · New Drug Application · Sponsor: ASCENDIS PHARMA BONE · Approved 2024-08-09

Drug application

FDA Application #

NDA216490

Application type

New Drug Application

Brand name

YORVIPATH

Generic name

PALOPEGTERIPARATIDE

Active ingredients

PALOPEGTERIPARATIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ASCENDIS PHARMA BONE

Manufacturer

Ascendis Pharma, Endocrinology, Inc.

First approval

2024-08-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown